We have determined the nucleotide sequences of the coding region in the last two coding exom of ABO genes (which occupy 91% of the soluble form of A' transferase) from 7 individuals with weak subgroup phenotypes. Four of thc individuals had an A, phenotype and 3 individuals had a B3 phenotype. We determined the nucleotide sequences based on PCR followed by subcloning and DNA sequencing of the amplified fragments. Two cases of the A' allele and lcase of the B' allele were found to contain a single-base substitution which resulted in an amino acid substitution. However, no other cases of A3 and B3 alleles were found to contain differences in this region. This finding demonstrates for the first time heterogeneity among these weak subgroups at the nucleotide level.
Introduction
Since the discovcry of the histo-blood group ABO system by Landsteiner in 1900 [l] , almost a century passed until we were successfully able to elucidate the molecular genetic basis of the three major alleles (A', B, and 0) at the blood group ABO gene locus by cloning A' transferase cDNA [2] , and by cloning B and 0 alleles [3] followed by nuclcotide sequencing. 0 alleles are characterized by the presence of a single-base delction close to the N-terminal of the coding sequence, which shifts the reading frame of codons and results in the translation of an entirely different protein thereafter without any activity of A or B transfcrases. A'-and B-allelic cDNAs are identical cxccpt for seven nucleotide substitutions resulting in four amino acid substitutions between A' and B transferases.
August 25. 1Y92 We have subsequently extended our study to subgroups. Subgroups of A, Al and A2 were first identified by von Dungern in 1911 when he found two kinds of group A crythrocytes. Sera from blood group B individuals contain two types of antibodies against A antigens: anti-A and anti-A,. Group A erythrocytes, which react with both anti-A and anti-Al were namcd A,, and those which react only with anti-A, were named A,. Dolichos biflorus lectin has been used as an anti-Al reagent. Wc analyzed A'/A? differences at the nucleotide level and found a single-base substitution and a single-base deletion in the coding sequence of the last coding exon of A2 alleles [4]. These two differences wcre found present in all the A' alleles tcstcd (8 specimens). The single-base delction is located close to the carboxyl terminal of the transferase in the coding sequence. As a result of frame shifting, A* transferase has an Here we report the identification of mutations in the nucleot ide sequences of the coding region in some cases of A3 and B-' alleles.
Materials and Methods

Blood C;roiiprng
We h,ive analyzed a total of 7 cases of weak subgroups; one A,B3, two A?, twoA,B, twoBi. Bloodgroups were determined using immunological methods. One case (A,B1) was confirmed to posses a B' allele through the grouping of its family members.
PCR .4 I I iplificu tion
Genomic DNA was prepared from blood specimens by Proteinase K-SDS method [6] . Reagents for PCR [7] reaction were purchased from Perkin-Elmer Cetus. The pairs of synthetic oligodeoxynucleotides used for PCR are as follows: fy-121, CGGAATTCCATGTGACCGCACGCCT and fy-122, CGGAATTCTCTACCCTCGGCCAf'C; fy-101, CG(jAAT"TCCCGTCCGCCTGCC~GCAG and fy-113, C'(j(;AATTCACCTCTTGCACCGACCC;
and fy-1 I 2. ('GGAATTCCGTTCTGCTAA A ACCAAG and fy-114. C'CTGGTGTGCGTGGAC, or fy-127, C'G GAATTCCTGGTGTGCGTGGAC. The oligodeoxynucleotide fy-127 is essentially identical to fy-114 except for the additional EcoRI site at the 5' end. All the EcoRI sites are artifical in order to facilitate the subsequent subcloning. The reaction mixture was denatured for 5 min at 95°C followed by 45 cycles of 30 s at94"C, 30sat55"C,and30 sat 72"CinaDNAthermalcycler. DNA was extracted with pheno1:chloroform:isoamylalcohol = 25:24:1 and precipitat ecl with ethanol.
Subcloning nnd DNA Sequencing After resuspension, DNA was digested with EcoRI, electrophoresed on :in iigarose gel. and the major fragments with expected size were excised and DNA was extracted with GeneClean kit (Bio 101). Gel-purified DNA was then ligated with either EcoRI-digested, dephosphorylated sequencing vector pT7T3U18 (Pharmacia-LKB) (fy-121-fy-122, fy-101-fy-113, and fy-112-fy-127), or the same vector double digested with EcoRI and SmaI (fy-112-fy-114). Ligated DNA was used to transform XLl-blue strain of Escherichia coli. Plasmid DNA was prepared from a multiple number of transformants, analyzed for theinsert, denatured. and usedfornucleotide sequencing by the Sanger method [8] with Sequenase (United States Biochemical). Figure 1 shows the schematic comparison of the nucleotide and the deduced amino acid sequences of each allele from 7 individuals 5howing phenotypes of weak subgroups, A3 or Bi, with those of A', 0, and B alleles.
Results
Two pairs of oligo primers, fy-101 & fy-113 and fy-112 & fy-114/fy-127, were used to amplify the coding sequence in the last coding exon. The corresponding sequence for primer fy-101 resides in the intron preceding this last coding exon (the last base of fy-101 is located just adjacent to the splicing acceptor site), and that of fy-112 resides in the 3' untranslated region (the last base of fy-112 is located 53 bases away from the termination codon on the 3' 4ide). Primers fy-113 and fy-1141fy-127 are homologous to the sequences in the last exon except for the artifical EcoRI sequences of fy-113 and fy-127, and the amplified fragments from these pairs of oligos overlap one another. The third pair of oligos was used to amplify the preceding exon. The corresponding sequences for fy-121 and fy-122 reside in the introns preceding and following this exon, respectively. The last base of fy-121 is located 16hases away from the 5' side of the splicing acceptor site and that of fy-122 is located 11 bases away from the 3' side of the splicing donor site. Nucleotide sequencing of multiple (more than 10) clones of transformants, transformed with each PCR-amplified fragment, was performed to discriminate between the two alleles on the two homologous chromosomes as well as the occasional errors introduced by Toq DNA polymerase. We were able to discriminate the two alleles on homologous chromosome pairs in 5 out of the7 samples tested, based on differences in the nucleotide sequences. However, even with our extensive sequencing we were unable to discriminate the two homologously paired alleles in the remaining 2cases (both with a phenotype of A?) in the coding sequence of the last coding exon. More than twenty transformant clones showed an identical sequence suggesting that these A' alleles are identical to A' alleles in this region. Figure 1 shows this conclusion. There appears [2] . Because only the last two coding exons were analyzed forA3 and B3 alleles, oiily the sequences in this region are compared and thc differcnccs arc indicatcd. For each specimen, the two alleles which made up homologous chromosome pairs were discriminated from one another by differences in the nucleotide sequences. For the two A'O individuals, we were unablc to discriminate between the two honiologously paircd allelcs in the last coding exon. We assume these A' alleles are identical to A' alleles in the last coding exon because no differences were found among more than twenty transformant cloncs. Thc figure shows this conclusion. The hatched rectangle in 0 alleles indicates the entirely different deduced amino acid sequence due to frame shifting caused by the single-base deletion. The arrow shows the N-terminal of the soluble form of A' transferasc . to be at least two kinds of A' and B' alleles. The A' alleles from two A3B individuals have a single-base substitution at nt. 871 (G + A) resulting in an amino acid substitution at aa. 291 (aspartic acid + asparagine) which discriminates these A3 alleles from A' alleles. The B3 allele from one AIBl individual has a single-base substitution at nt. 1054 (C+ T) resulting in an amino acid substitution at aa. 352 (arginine + tryptophan), which discriminates this B3 allele from B alleles.
Discussion
Heterogeneity among the single subgroups has been reported for A and B variants based on the analysis of transferase activity in the serum of these individuals. Cartron et al. [9] reported three types of A, phenotypes. One group consisted of A3 phenotypes with a low lcvcl of A transferase activity in the serum, and the optimal pH of the transferase was approximately 7 (in 7 out of 11 cases). The second group consisted of A3 phenotypes with no activity of A transferase (3 out of the 11). A high A trans-ferase 'ictivity optimum at pH 6 was detected in the last of eleven A , samples. Nakamura et al. [lo] reported an active A trnnsferase which has characteristics (the level of activit), pH optimum, K,, V,,,,, and heat stability) identical to thme of A' transferase in the serum of A 3 phenotypes. These authors postulated that the weak A expression is duc to the suppression of A transferase production only in hemopoietic tissues. B transferase activity in the serum o f individuals with B7 phenotype has been reported to vary from 10 to 100% of control level [ll] . Due to the restricted availability of blood specimens, we have not yet performed any enzymological analyses.
Bec'me of our incomplete knowledge of the exon-intron boundaries of ABO genes and the restricted availability ot \ample specimens, we focused our efforts on the identification of differences in the coding sequence of the last two coding exons. Although there may be more differences wmewhere outside of these exons (including differences i n the splicing pattern), 91% of the soluble form of A' tran\fcrase is contained in these two exons and extensive nucleotide and deduced amino acid sequence homologies wt th a1 +3 galactosyltransferase gene are observed only in this region [12] suggesting the importance of the last two coding exons for transferase activity.
We liave identified nucleotide substitutions, which result in cimino acid substitutions, in the last coding exon of some ot A ' and B' alleles. The fact that these differences were n o t found common to all the samples with the same weak subgroups indicates heterogeneity in each group.
There is a possibility that only those cases which identify differences in the nucleotide sequence are genuine weak subgroups and the rest are caused by changes in physical conditions due to illness, diet etc. A decrease of A and B antigens in patients with leukemia has been well documented [13] .
The computational calculation using the IBI Pustell Sequence Analysis Program indicates the decrease of flexibility around these amino acid substitutions (aspartic acid + asparagine at aa. 291 in two A3 alleles and arginine + tryptophan at aa. 352 in a B' allele) as well as the changes in the isoelectric point. The amino acid substitution at aa. 291 has also been calculated to disrupt the a-helix structure around this amino acid. These changes may be responsible for the weak activities of these alleles. Future studies by molecular biological approaches (construction of expression constructs with these nucleotide and resulting amino acid substitutions and expression study by DNA transfection) may clarify whether these changes are sufficient for explaining these weak phenotypes. When the complete exon-intron boundaries and promoter sequences are defined for ABO genes, mutations in other A3 and B3 alleles will be clearly identified.
